Pain control after thyroid surgery
Phase 4
- Conditions
- Health Condition 1: E079- Disorder of thyroid, unspecified
- Registration Number
- CTRI/2023/07/054897
- Lead Sponsor
- Max Super Specilaity Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a.Patient aged above 18 years
b.Patients planned for thyroid or parathyroid surgery.
Exclusion Criteria
a.Patient refusal
b.Thyroid gland diameter more than 8 cm
c.Retrosternal goitre
d.Anticipated lymph node dissection
e.Patients on beta blockers
f.Allergy to local anaesthetics.
g.Patients with a history of bronchial asthma
h.Patients with renal impairment (eGFR less than 30 ml/min/1.73 m2)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the efficacy of ultrasound-guided capsule-sheath block in reducing VAS scores at 4 hours after thyroid surgery.Timepoint: Checked at 4 hours after surgery.
- Secondary Outcome Measures
Name Time Method 1)To evaluate the efficacy of ultrasound-guided capsule-sheath block in reducing VAS scores at 30 min, 8 & 12 hours after surgery <br/ ><br>2)To evaluate the efficacy of ultrasound-guided capsule-sheath block in decreasing the time to first analgesic use postoperatively. <br/ ><br>3)To evaluate the efficacy of ultrasound-guided capsule-sheath block in reducing total analgesic use in the first 12 hours after surgery. <br/ ><br>4)To evaluate the postoperative side effects of ultrasound-guided capsule-sheath block. <br/ ><br>Timepoint: 30min, 8 & 12 hrs after surgery